{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigfymbu3mpqg22fenrjw6piybx3sgazsd7p2oek26gplkaeev6a64",
    "uri": "at://did:plc:2gbt2dlwaqovtnmxkat3tyke/app.bsky.feed.post/3mfawfj5rjal2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig7isbmpemo3q5hnr5oeogilyuj2qplvt3u4rtdk3wuc4pqrcflau"
    },
    "mimeType": "image/jpeg",
    "size": 48798
  },
  "path": "/articles/d41586-026-00365-7",
  "publishedAt": "2026-02-20T01:10:40.455Z",
  "site": "https://www.nature.com",
  "tags": [
    "doi:10.1038/d41586-026-00365-7"
  ],
  "textContent": "Nature, Published online: 19 February 2026; doi:10.1038/d41586-026-00365-7\n\nIsomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left guessing how to achieve similar results.",
  "title": "‘An AlphaFold 4’ – scientists marvel at DeepMind drug spin-off’s exclusive new AI",
  "updatedAt": "2026-02-19T00:00:00.000Z"
}